DICHROIC-DYE-DOPED ISOTROPIC CHIRAL LIQUID CRYSTALS
    191.
    发明申请
    DICHROIC-DYE-DOPED ISOTROPIC CHIRAL LIQUID CRYSTALS 审中-公开
    DICHROIC-DYE-DOPED ISOTROPIC CHIRLAL液晶

    公开(公告)号:US20160145493A1

    公开(公告)日:2016-05-26

    申请号:US14898315

    申请日:2013-06-14

    Abstract: Disclosed are polarization-independent electro-optical compositions using dichroic-dye-doped polymer stabilized optically isotropic chiral liquid crystals. The isotropic phase of such compositions can be well maintained even if the temperature is below 0° C. The electro-optical performances of such compositions demonstrate large Kerr constants, fast response times, and large contrast ratios of the compositions. The power consumption and the cost of devices based on the compositions can be decreased substantially due to alignment-free and polarizer-free characteristics. The compositions can be used to generate low power consumption displays and other photonic devices.

    Abstract translation: 公开了使用二色性染料掺杂聚合物稳定的光学各向同性手性液晶的与偏振无关的电光组合物。 即使温度低于0℃,这种组合物的各向同性相也能得到很好的保持。这些组合物的电光学性能表现出较高的克尔常数,快速的响应时间和组合物的较大对比度。 由于无对准和无偏振特性,基于组合物的功率消耗和器件的成本可以显着降低。 该组合物可用于产生低功耗显示器和其它光子器件。

    PREPARATION OF METAL OXIDE-GRAPHENE COMPOSITE FILMS
    192.
    发明申请
    PREPARATION OF METAL OXIDE-GRAPHENE COMPOSITE FILMS 有权
    金属氧化物 - 石墨复合膜的制备

    公开(公告)号:US20160020040A1

    公开(公告)日:2016-01-21

    申请号:US14773216

    申请日:2013-03-05

    CPC classification number: H01G11/86 C01B32/23

    Abstract: Methods of making metal oxide-graphene composites are disclosed. The methods can include, for example, providing a composition including graphene oxide and at least one substrate, the composition being dispersed in a liquid medium. The methods can also include, for example, providing a composition including graphene oxide and at least one substrate, heating the composition, and cooling the composition. Compositions useful for performing the methods and composites obtained by the process are also disclosed.

    Abstract translation: 公开了制备金属氧化物 - 石墨烯复合材料的方法。 所述方法可以包括例如提供包含氧化石墨烯和至少一种底物的组合物,所述组合物分散在液体介质中。 所述方法还可以包括例如提供包含氧化石墨烯和至少一种底物的组合物,加热组合物并冷却组合物。 还公开了用于执行通过该方法获得的方法和复合材料的组合物。

    USE OF FUSION PROTEIN
    193.
    发明申请
    USE OF FUSION PROTEIN 有权
    使用融合蛋白

    公开(公告)号:US20150337025A1

    公开(公告)日:2015-11-26

    申请号:US14653276

    申请日:2013-12-05

    Abstract: Disclosed is the use of a fusion protein in drugs for stimulating differentiation of bone marrow mesenchymal stem cells to hematopoietic stem/progenitor cells, or drugs for proliferation of granulocyte hematopoietic progenitor cells. The fusion protein has a sequence as shown in SEQ ID NO: 2 or SEQ ID NO: 4. The drugs can be used for the prevention and/or treatment of (i) hematopoietic dysfunction caused by chemotherapy, (ii) hematopoietic dysfunction caused by radiotherapy, or (iii) leukopenia.

    Abstract translation: 公开了在药物中使用融合蛋白来刺激骨髓间充质干细胞分化成造血干细胞/祖细胞或用于粒细胞造血祖细胞增殖的药物。 融合蛋白具有如SEQ ID NO:2或SEQ ID NO:4所示的序列。该药物可用于预防和/或治疗(i)由化疗引起的造血功能障碍,(ii)造血功能障碍引起的 放射治疗,或(iii)白细胞减少。

    Precursor solution, a perovskite solar cell and a preparation method thereof

    公开(公告)号:US12213330B2

    公开(公告)日:2025-01-28

    申请号:US17630356

    申请日:2021-04-28

    Abstract: The disclosure provides a precursor solution, a perovskite solar cell and a preparation method thereof. The solute of the precursor solution includes a metal halide, the solvent of the precursor solution is an organic solvent, and the precursor solution contains nanobubbles, which have a diameter not more than 1000 nm, and the zeta potential of the precursor solution does not exceed-20 mV. The method of preparing the precursor solution includes: (1) preparing an organic solvent containing nanobubbles; (2) dissolving a solute in the organic solvent containing nanobubbles. The precursor solution of the disclosure has a very low zeta potential, and the nanobubbles can exist stably in the organic solvent(s) for up to one month. When comparing with traditional methods for preparing the precursor solution of the perovskite cells, the method for preparing the precursor solution of the disclosure can effectively improve the stability, reproducibility and solubility of the metal halide in the organic solvent(s).

    PREPARATION METHOD FOR COMPOUND FASUDIL HYDROCHLORIDE

    公开(公告)号:US20240287027A1

    公开(公告)日:2024-08-29

    申请号:US18570511

    申请日:2022-05-26

    CPC classification number: C07D401/12

    Abstract: An efficient and economical method for synthesizing Fasudil hydrochloride includes the synthesis route starts with inexpensive and readily available ethylenediamine as the starting material, obtains intermediate tert butyl-(N-(2-aminoethyl)-5-isoquinoline sulfonamide) carbamate (5) through sulfonylation and Boc protection, and then obtains Fasudil hydrochloride through a stacking process, which includes four steps: nucleophilic substitution, deprotection, cyclization, and salt formation. The total yield of Fasudil hydrochloride (1) is 67.1%, with a purity of up to 99.94%. Compared with traditional processes, the route avoids the use of expensive homopiperazine and its derivatives as synthetic intermediates. The advantages of the process include cheap and easy to obtain raw materials, simple operation, low cost, environmental friendliness, and suitability for industrial production.

Patent Agency Ranking